These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38582057)

  • 1. Medical management of pediatric inflammatory bowel disease.
    Pasternak B
    Semin Pediatr Surg; 2024 Apr; 33(2):151398. PubMed ID: 38582057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current therapy of inflammatory bowel disease in children.
    Rufo PA; Bousvaros A
    Paediatr Drugs; 2006; 8(5):279-302. PubMed ID: 17037946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current therapeutic approaches in inflammatory bowel disease.
    Sohrabpour AA; Malekzadeh R; Keshavarzian A
    Curr Pharm Des; 2010; 16(33):3668-83. PubMed ID: 21128898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Management of Inflammatory Bowel Disease.
    Rahman S; Patel RK; Boden E; Tsikitis VL
    Surg Clin North Am; 2024 Jun; 104(3):657-671. PubMed ID: 38677828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of inflammatory bowel disease in adults.
    Katz JA
    J Dig Dis; 2007 May; 8(2):65-71. PubMed ID: 17532817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy of inflammatory bowel disease.
    Sack DM; Peppercorn MA
    Pharmacotherapy; 1983; 3(3):158-76. PubMed ID: 6136027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management].
    Bakulin IG; Skalinskaya MI; Maev IV; Skazyvaeva EV; Zhuravleva MS; Gaikovaya LB; Bakulina NV; Ermakov AI; Alekseenko ES; Ivanova KN; Solovev MV
    Ter Arkh; 2021 Aug; 93(8):841-852. PubMed ID: 36286877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inflammatory bowel disease: an overview].
    Herrlinger K
    Med Monatsschr Pharm; 2013 Nov; 36(11):402-8; quiz 409. PubMed ID: 24640117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroenterologists' Perceptions Regarding Ulcerative Colitis and Its Management: Results from a Large-Scale Survey.
    Lasch K; Liu S; Ursos L; Mody R; King-Concialdi K; DiBonaventura M; Leberman J; Dubinsky M
    Adv Ther; 2016 Oct; 33(10):1715-1727. PubMed ID: 27509887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?
    Agrawal M; Colombel JF
    Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):421-436. PubMed ID: 31078245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helminth therapy (worms) for induction of remission in inflammatory bowel disease.
    Garg SK; Croft AM; Bager P
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009400. PubMed ID: 24442917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and therapeutic characterisation of a multicentre cohort of patients with inflammatory bowel disease in Colombia.
    Parra-Izquierdo V; Flórez Sarmiento C; Frías-Ordoñez JS; Vargas M; Kock J; Lozano Escobar N; Márquez JR
    Gastroenterol Hepatol; 2023 Oct; 46(8):585-593. PubMed ID: 36464080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current concepts about the treatment of inflammatory bowel disease, biological therapy].
    Bosques-Padilla FJ; Galindo-Marines SL; Yamamoto-Farusho JK
    Rev Gastroenterol Mex; 2008; 73(4):217-30. PubMed ID: 19666271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease.
    Beattie RM; Croft NM; Fell JM; Afzal NA; Heuschkel RB
    Arch Dis Child; 2006 May; 91(5):426-32. PubMed ID: 16632672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The state of the art in the management of inflammatory bowel disease.
    Hanauer SB; Present DH
    Rev Gastroenterol Disord; 2003; 3(2):81-92. PubMed ID: 12776005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical and recent advances in the treatment of inflammatory bowel diseases.
    Sales-Campos H; Basso PJ; Alves VB; Fonseca MT; Bonfá G; Nardini V; Cardoso CR
    Braz J Med Biol Res; 2015 Feb; 48(2):96-107. PubMed ID: 25466162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data.
    Long GH; Tatro AR; Oh YS; Reddy SR; Ananthakrishnan AN
    Adv Ther; 2019 Nov; 36(11):3079-3095. PubMed ID: 31562607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.